#ChatsWithChaudhrey the Podcast Rizwan Chaudhrey

 I caught up with Annabel this week as part of my #ReflectionsandForecasts,series. We discussed #Tio2, #supplychain, #forecasting,  #drugsecurity, #wellness and more.
I asked Annabel....
2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 
• Can you give me a quick overview of Colorcon? 00:44
• One word to describe 2022 and why? 01:05
• What were some of Colorcon’s achievements in 2022? 02:07
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 03:09
• How did Colorcon overcome the challenges around Supply Chain? 03:52
• Are there any areas you think the industry could improve? 04:29


2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬
• What are your predictions for #Pharma in 2023? 05:17
• What developments and trends do you expect to see/predict in #TabletCoatings and #DrugSecurity, and what can we expect from Colorcon in 2023? 06:12
• Finally, what last thoughts would you like to leave viewers with for 2023? 07:07
If you have any questions for Annabel please leave them below in the comments.
🎞 Watch  the interview here https://lnkd.in/eVM_YCuR
You can find out more about #Colorcon and their solutions at www.colorcon.com

2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬
• Can you give me a quick overview of ApiJect? 00:512
• What were some of ApiJect achievements in 2022? 03:21
• One word to describe 2022 and why? 05:33
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 05:44
• Are there any areas you think the industry could improve? 09:06

2023 Forecasts
• What are your predictions for BioPharma/ Pharma in 2023? 10:36
• What developments and trends do you expect to see/predict in the use of Blow Fill seal and Drug delivery for Vaccines, and what can we expect from ApiJect in 2023? 16:20
• Finally, what last thoughts would you like to leave viewers with for 2023? 18:30

🎞 Watch the interview here https://lnkd.in/ew6cdqPf

You can learn more about ApiJect by visiting www.Apiject.com


This post is sponsored by ApiJect

I sat down with Julie Waras Brogren. Deputy CEO for Biotech Ascelia Pharma as part of my #ReflectionsandForecast20222023 interview series.

I asked Julie...

2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬
✺ For those who are not familiar, please give us a quick introduction to you and Ascelia Pharma. 01:05
✺ In what way is your technology innovative and how does it differ from other products on the market? 02:22
✺ What is Orviglance and what stage are you currently at with Orviglance? 05:01
✺ One word to describe 2022 and why? 05:23
✺ What were some of company's key achievements in 2022? 06:18
✺ Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? Are there any trends and challenges you are noticing as an emerging biotech company? 07:54
✺ Has it been difficult to get investment for non-covid related #drugdevelopment? 09:35
✺ Is Ascelia’s #ClinicalTrials program global and was it impacted by #Covid? 10:17
✺ Are there any areas you think the industry could improve? 11:33

2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬
✺ What are your predictions for #LifeScience/ #Pharma/ #BioPharma in 2023? 12:57
✺ What developments and trends do you expect to see/predict in #orphanoncology treatments? 14:42
✺Lets look more specifically at Ascelia in 2023 and beyond. As a #biotech with a developing portfolio, where is your focus, what are your 2-3 year objectives? 17:22
✺ In terms of the future, what partnerships and collaborations would be ideal for advancing the company’s growth? 19:14
✺ Finally, what last thoughts would you like to leave viewers with for 2023? 22:09

Feel free to leave any questions or comments for Julie below.

🎞 You can WATCH the interview here https://lnkd.in/enT7WtC3

You can learn more about #AsceliaPharma at www.Ascelia.com

I was delighted to catch up with Cherwell Laboratories MD Andy Whittard as part of this years #RefelectionsandForecasts interview series.
We talked about Cherwell Laboratories, their achievements in 2022,  their "Delivery Knowledge" platform, meeting the challenges in 2022, the impact of #Annex1 on #EnviromentalMonitoring, #ContinuousMonitoring, #supplychain, co-operation, and sustainability.
2022 Reflections 
• Can you give me a quick overview of Cherwell Laboratories? 00:39
• One word to describe 2022 and why? 01;50
• What were some of Cherwell Laboratories key achievements in 2022? 04:40
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 05:29
• How have Cherwell managed customers expectations due to the challenges around Supply Chain issues? 08:03
• Did Andy think that dealing with the Covid19 period helped the business become more "agile"? 09:33
•  When Annex 1 came out in August was it what Andy expected it to be? 11:33
• Are there any areas you think the industry could improve? 13:13
 2023 Forecasts
• What are your predictions for the Life Science/Pharma/ BioPharma in 2023? 15:14
• What developments and trends do you expect to see/predict in contamination control with the new Annex One Updates? 17:49
• Where does  Andy think AI and Machine learning can help in Environmental Monitoring?24:14 
• What can we expect from Cherwell Laboratories 2023? 25:52
• Finally, what last thoughts would you like to leave viewers with for 2023? 29:09
You can check out #Cherwells  online EU #GMP and #Annex resources page which provides further background and insight on the latest regulatory update governing the manufacture of #sterile #medicinalproducts, at https://lnkd.in/geW5f2EV
and learn more about Cherwell Laboratories at www.cherwell-labs.co.uk


You can WATCH the interview here https://lnkd.in/ecsqJjK6

Here's Episode 2 of #ReflectionandForecasts2223 series with my good friend Oliver Stauffer CEO of #PTI

We spoke about the impact of #ATMPs and #Biologics on #ClosedContainerIntegrity Testing, The growth of #CDMO's, #SupplyChain, #AI, #MachineLearning, #Automation, #Collaboration, #Annex1 and more.

I asked Oliver...

2022 Reflections
• Can you give me a quick overview of #PTI? 00:46
• One word to describe 2022 and why? 01:32
• What were some of PTI key achievements in 2022? 02:50
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 03:59
• How have the growth of the Biologics and ATMP impacted the technologies required for #CCIT? 05:53
• Are there any areas you think the industry could improve? 07:25

2023 Forecasts
• What are your predictions for #Pharma/ #BioPharma in 2023? 08:26
• Did Oliver think the trends in 2023, would be different for North America and Europe due to Annex 1? 9.29
• What developments and trends do you expect to see in #CCITesting and the impact Annex 1 will have in that area? 11:53
• What role will AI and Machine Learning impact on #CCIT? 13:17
• Does Oliver think collaborations will continue in the industry? 14:38
• What can we expect from PTI in 2023? 16:57
• Finally, what last thoughts would you like to leave viewers with for 2023? 18:26

I am delighted to be kicking off this years #ReflectionsandForcasts series with Carsten Press SVP Key Account Management, Supply Chain and Marketing, CDMO #VetterPharma


We had a really interesting discussion covering #Sustainability, #Robotics, the role of #CDMO's, #SupplyChainSecurity, #collaboration, and more.


I asked Carsten...


2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 
✹ Can you give me an overview of yourself and your role at Vetter Pharma? 00:58
✹ Can you give me a quick overview of Vetter Pharma? 01:45
✹ One word to describe 2022 and why? 03:13
✹ How has Vetter changed since the pandemic? 03:51
✹ What were some of Vetter's key achievements in 2022? 05:12
✹ Looking back at 2022 what industry trends, stood out for you? 07:03
✹ Has the role of CDMO's changed over the past few years? 08:26
✹ Are there any areas you think the industry could improve? 10:34
✹ What has driven Pharma's large carbon footprint? 11:20


2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬
✹ What are your predictions for the #LifeScience/#Parma sector in 2023? 12:17
✹ What developments and trends do you expect to see/predict in the area of Pharma manufacturing? 13:34
✹ How have Vetter ensured #securityofsupply? 15:18
✹ What is the alliance with Rentschler Biopharma SE, how is it going to work, and does Carsten believe that collaboration with other companies is the way forward in Pharma? 18:20
✹ What can we expect from Vetter Pharma in 2023? 21:39
✹ Finally, what last thoughts would you like to leave viewers with for 2023? 23:01
You can see  Vetter Pharma  sustainability report here
https://lnkd.in/ea89cRXw
nd learn more about Vetter Pharma here https://lnkd.in/eeGkdGPf


#RSKVetterPharma #ReflectionsandForecasts20222023
#DrugDiscoverytoDrugDelivery, #Pharma , #Biopharma , #Biotech, 
#ClinicalManufacturing #DrugManufacturing #PharmaManufacturing


You can watch the video version of this interview here  https://lnkd.in/eUzzs-HV